CEDIPROF INC FDA Approval NDA 021342

NDA 021342

CEDIPROF INC

FDA Drug Application

Application #021342

Documents

Letter2003-12-11
Letter2003-08-28
Letter2004-06-24
Letter2004-06-24
Label2002-03-01
Label2008-06-12
Label2009-06-22
Review2002-06-19
Letter2002-03-01
Letter2008-06-13
Letter2008-06-13
Letter2009-06-17
Letter2011-03-11
Label2003-12-11
Label2003-08-28
Label2008-06-12
Review2005-05-13
Review2005-05-13
Letter2017-12-07
Label2017-12-07
Review2002-06-19

Application Sponsors

NDA 021342CEDIPROF INC

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004
Prescription005
Prescription006
Prescription007
Prescription008
Prescription009
Prescription010
Prescription011
Prescription012

Application Products

001TABLET;ORAL0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
002TABLET;ORAL0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
003TABLET;ORAL0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
004TABLET;ORAL0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
005TABLET;ORAL0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
006TABLET;ORAL0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
007TABLET;ORAL0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
008TABLET;ORAL0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
009TABLET;ORAL0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
010TABLET;ORAL0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
011TABLET;ORAL0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM
012TABLET;ORAL0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium0LEVO-TLEVOTHYROXINE SODIUM

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP2002-03-01STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2003-08-21STANDARD
EFFICACY; EfficacySUPPL3AP2004-06-23UNKNOWN
EFFICACY; EfficacySUPPL4AP2004-06-23STANDARD
LABELING; LabelingSUPPL8AP2008-06-10STANDARD
LABELING; LabelingSUPPL14AP2008-06-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2009-06-14STANDARD
EFFICACY; EfficacySUPPL20AP2011-03-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL22AP2012-11-20STANDARD
LABELING; LabelingSUPPL23AP2017-12-05STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2015-02-09STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL25AP2017-01-12STANDARD

Submissions Property Types

ORIG1Null31
SUPPL2Null0
SUPPL16Null0
SUPPL20Null6
SUPPL22Null0
SUPPL23Null15
SUPPL24Null0

TE Codes

001PrescriptionAB1
002PrescriptionAB1
003PrescriptionAB1
004PrescriptionAB1
005PrescriptionAB1
006PrescriptionAB1
007PrescriptionAB1
008PrescriptionAB1
009PrescriptionAB1
010PrescriptionAB1
011PrescriptionAB1
012PrescriptionAB1

CDER Filings

CEDIPROF INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21342
            [companyName] => CEDIPROF INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LEVO-T","activeIngredients":"LEVOTHYROXINE SODIUM","strength":"0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"12\/05\/2017","submission":"SUPPL-23","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/021342s023lbl.pdf\"}]","notes":""},{"actionDate":"06\/14\/2009","submission":"SUPPL-16","supplementCategories":"Manufacturing (CMC)-Control","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/021342s016lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"06\/10\/2008","submission":"SUPPL-14","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021342s008s014lbl.pdf\"}]","notes":""},{"actionDate":"06\/10\/2008","submission":"SUPPL-8","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021342s008s014lbl.pdf\"}]","notes":""},{"actionDate":"12\/08\/2003","submission":"SUPPL-1","supplementCategories":"Manufacturing (CMC)-Control","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/21342scs001_Levo-T_lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"08\/21\/2003","submission":"SUPPL-2","supplementCategories":"Manufacturing (CMC)-Control","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/21342scs002_levoT_lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"03\/01\/2002","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2002\\\/21342lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LEVO-T","submission":"LEVOTHYROXINE SODIUM","actionType":"0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2017-12-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.